| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0007 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0008 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0009 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.001 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.001 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.13 | 0.001 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.001 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.002 |